Traws Pharma holds annual shareholder meeting in virtual format

• Traws Pharma held its annual shareholder meeting on July 8, 2026.
• Shareholders adopted an amendment to the 2021 Incentive Compensation Plan, adding 2 million shares for issuance and making administrative changes.
• The plan amendment took effect on July 8, 2026; the filing does not indicate any awards or issuances have been made under the expanded pool.
• Shareholders also approved seven director nominees to serve until the 2027 annual meeting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Traws Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-082250), on July 09, 2026, and is solely responsible for the information contained therein.